Hadassah

Patient Number Three Saved at Hadassah with World-First Stem Cell Treatment

Thursday, Sep 27 2012

With a world-first placental stem-cell (PLX) treatment, developed by Pluristem, doctors at the Hadassah University Medical Center have saved the life of a third patient suffering from bone marrow disease.

"Following three successful treatments, which were conducted for the first time in the world at the Hadassah Medical Center,” relates Prof. Reuven Or, Director of Hadassah’s Bone Marrow Transplantation and Cancer Immunology Department, “we can say that PLX cells from the placenta saved the life of patients suffering from bone marrow failure. We are very encouraged by the results and hope that future clinical trials will show the effectiveness of the PLX cells. I believe that the PLX treatment holds huge hope for patients who suffer from different conditions of bone marrow failure and, once approved, will be available for every patient who needs it.”

This most recent patient, a 45-year-old man who has acute myeloid leukemia, a form of blood cancer, had undergone chemotherapy and an unrelated bone marrow transplant, but still suffered from a life-threatening shortage of white blood cells. After receiving two intramuscular injections of the placental stem cells, one week apart, his clinical condition and overall well being improved significantly enough for him to be released from the hospital.

In addition to helping the three patients, Pluristem Chief Executive Officer Zami Aberman notes, the data suggests that the PLX cells may be helpful in rescuing both bone marrow transplant failures that were allogeneic (genetically different) as well as autologous (from the patient’s own cells).

 


Read more on Hadssah's Stem Cell Treatment

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More